Page results
-
Clinician researchers at UCLH and UCL are leading a major UK clinical trial to test whether proton beam therapy (PBT) can significantly improve survival for patients with mesothelioma, a rare and aggressive cancer of the lining of the lung.
-
Having proton beam therapy: information for teenagers aged 13-17 patient information.
-
Having proton beam therapy: information for children aged 9-12 patient information
-
Having proton beam therapy: information for children aged 5-8 patient information page.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.
-
This page answers common questions asked by colorectal patients.
-
Information on how we ask for your consent to treatment, and Martha's Rule.
-
UCLH is accelerating clinical trial delivery so that patients gain access to new treatments sooner. The acceleration is happening through close collaboration between research teams and clinical services.
File results
-
FOI/2023/0156 - Digital sepsis alerts for obstetric patients
-
FOI/2023/0159 - Local treatment guidelines for Atopic Dermatitis (Atopic Eczema)
-
FOI/2023/0162 - ICT and Procurement strategy and organisational charts
-
FOI/2023/0174 - Integration Engine (IE) within Trust's IT estate
-
FOI/2023/0175 - Treatment for Myelofibrosis
-
FOI/2023/0180 - Treatment guidelines for chronic kidney disease/ diabetic kidney disease
-
FOI/2023/0182 - Data privacy compliance tools
-
FOI/2023/0187 - Treatment for urothelial and colorectal cancer
-
FOI/2023/0192 - Non emergency patient transport - NEPTS and taxi procurement
-
FOI/2023/0195 - Patient level costing system and integrated data platform